History of rHGH
Human growth hormone (HGH) is linked to anti-aging and general overall health. It is a complex hormone that contains 191 amino acids that influence nearly all aspects of good health including increased metabolic rate, increased muscle mass, reduction of fat, improved skin appearance, and many other health benefits. Its positive benefits to the human body became known through years of medical research and treatments.
As early as 1958, endocrinologist Maurice Rabin injected growth hormone derived from pituitary glands taken from cadavers to treat a teenager, who was diagnosed with low levels of growth hormone. This treatment became known as Cadaver GH because it was procured from the pituitary glands of the deceased. The successful treatment increased medical interest in growth hormone, and it became more widely used even though it was not yet regulated. In 1960 the government decided to monitor the distribution of Cadaver GH and began restricting its use.
Ten years later Kabi, a Swedish pharmaceutical company, began to purchase pituitary glands for hospitals in Europe. Since pituitary glands were in limited supply, Cadaver GH treatment became very expensive, and therefore restricted to patient with severe conditions. At the same time, ongoing research indicated that Cruetzfeldt-Jacob disease, a fatally degenerative brain disease, could be contracted by neurological operations. However, Cadaver GH treatment was not yet linked to Cruetzfeldt-Jacob’s disease.
In 1981, United States based Genentech and Kabi combined forces to develop rhGH, a synthetic growth hormone created using a biosynthetic process. The rhGH hormone was called Somatrum and duplicated the 191 amino acids found in naturally made human growth hormone. Initially, the rhGH product was not approved, but in 1985, four adults were diagnosed with Cruetzfeldt-Jacob’s disease and eventually GH Cadaver treatments were linked to Cruetzfeldt-Jacob’s disease. The combination of a limited supply of pituitary glands and the life-threatening disease contracted by former Cadaver GH patients influenced the government to approve the recombinant human growth hormone in 1985. Later studies refined the process of creating recombinant growth hormone and more advanced protein secretion technology was developed, which produced a biosynthetic hormone called Somatropin.
In the mid-1990s Anti Aging Laboratories developed the first oral recombinant human growth hormone spray. Unlike human growth hormone injections, rhGH spray contains only a small amount of human growth hormone, eliminating the possibility of overdose. Since rhGH contained very small amounts of human growth hormone, it is more cost-efficient and more readily available to consumers who wanted the benefits of human growth hormone without painful injections or high expenses. Recombinant human growth spray allows the body to absork HGH evenly and can be administered in increments several times a day. Recombinant growth hormone spray, like many homeopathic remedies, stimulates the body to heal itself.
A quality rhGH spray may help you feel more energetic, increase muscle mass and have tighter more elastic looking skin. The many benefits linked to recombinant human growth hormone and our careful system of processing rhGH Complex Spray helps make it the right recombinant growth hormone spray for today’s consumer who wants to benefit from homeopathic HGH treatment.